PB-EF1a-TetOn3G Citations (3)
Originally described in: Expandable Arterial Endothelial Precursors from Human CD34(+) Cells Differ in Their Proclivity to Undergo an Endothelial-to-Mesenchymal Transition.Miller AZ, Satchie A, Tannenbaum AP, Nihal A, Thomson JA, Vereide DT Stem Cell Reports. 2018 Jan 9;10(1):73-86. doi: 10.1016/j.stemcr.2017.12.011. PubMed Journal
Articles Citing PB-EF1a-TetOn3G
| Articles |
|---|
| Quiescent cancer cells resist T cell attack by forming an immunosuppressive niche. Baldominos P, Barbera-Mourelle A, Barreiro O, Huang Y, Wight A, Cho JW, Zhao X, Estivill G, Adam I, Sanchez X, McCarthy S, Schaller J, Khan Z, Ruzo A, Pastorello R, Richardson ET, Dillon D, Montero-Llopis P, Barroso-Sousa R, Forman J, Shukla SA, Tolaney SM, Mittendorf EA, von Andrian UH, Wucherpfennig KW, Hemberg M, Agudo J. Cell. 2022 May 12;185(10):1694-1708.e19. doi: 10.1016/j.cell.2022.03.033. Epub 2022 Apr 20. PubMed |
An integrated pipeline for mammalian genetic screening.
Kramme C, Plesa AM, Wang HH, Wolf B, Smela MP, Guo X, Kohman RE, Chatterjee P, Church GM.
Cell Rep Methods. 2021 Sep 27;1(6):100082. doi: 10.1016/j.crmeth.2021.100082. eCollection 2021 Oct 25.
PubMed
Associated Plasmids |
| Broadening prime editing toolkits using RNA-Pol-II-driven engineered pegRNA. Huang S, Zhang Z, Tao W, Liu Y, Li X, Wang X, Harati J, Wang PY, Huang X, Lin CP. Mol Ther. 2022 Sep 7;30(9):2923-2932. doi: 10.1016/j.ymthe.2022.07.002. Epub 2022 Jul 6. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.